NCT05200598

Cardiovascular Risk Predictors in Patients With Psoriasis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 200 (actual)
• Sponsor: I.M. Sechenov First Moscow State Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Accepted

Summary

The investigators are planning to find the right modification of traditionally used risk scores (PASI, DLQI) in patients with psoriasis of different severity to guide the treatment that could potentially extend life, improve cardiovascular outcomes and quality of life in patients with psoriasis and cardiovascular risk factors in a prospective observational study. The traditionally excluded groups of older patients with diabetes mellitus, decreased kidney function and those with potentially worse prognosis are going to be included in the study. As it's known, the number of those patients is on the rise each year and require a close attention of multidisciplinary teams.

Conditions

• Psoriasis
• Cardiovascular Diseases

Timeline

• Start date: 2021-10-01
• Primary completion: 2023-09-01
• Completion: 2024-09-01
• First posted: 2022-01-21
• Last updated: 2024-10-08

Locations

1 site across 1 country: Russia